Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: A review

Radiation-induced double strand breaks or gemcitabine-induced replication stress trigger the activation of ataxia telangiectasia mutated (ATM) and ATM and Rad3-related (ATR) kinases, respectively (). Active ATM/ATR phosphorylate and activate Chk1 and Chk2 (-) which phosphorylate Cdc25 phosphatases, leading to their inactivation through degradation (Cdc25A) or cytoplasmic sequestration (Cdc25C) (, ). In the absence of Cdc25 phosphatase activity, cyclin dependent kinases (Cdk1 and Cdk2) remain bound by inhibitory phosphorylations, resulting in arrest of the cell cycle at G1/S, intra-S, or G2/M. Treatment of cells with gemcitabine prior to radiation results in radiosensitization that can be attributed to a number of events (Box 1), including dATP depletion and S-phase arrest. Inhibition of Chk1 sensitizes cells to gemcitabine and radiation by a number of potential mechanisms including abrogation of cell cycle arrest, premature mitotic entry, and inhibition of Rad 51 focus formation resulting in impaired homologous recombination repair (HRR).EGFR is phosphorylated in response to radiation or gemcitabine by an unknown mechanism(s) (). Radiation triggers translocation of EGFR into the nucleus (, ). This process coincides with transport of Ku70/80 and protein phosphatase 1 into the nucleus, resulting in increases in DNA-PK, repair of DNA-strand breaks (NHEJ; nonhomologous endjoining), and cell survival. Activation of EGFR in response to gemcitabine can also result in activation of the survival signal AKT (). Activating Ras mutations can result in activation of Ras-dependent pathways, such as PI3K/AKT, even in the presence of EGFR inhibitors. EGFR inhibitors prevent gemcitabine and/or radiation-mediated EGFR signaling and are thought to impair cell survival signals and DNA repair. EGFR inhibition blocks nuclear transport of EGFR and DNA-PK activity (, ). In some instances, phosphorylation of EGFR by gemcitabine promotes ubiquitination of the receptor leading to degradation along a proteosome/lysosome pathway (). EGFR degradation results in down-regulation of the survival signal pAKT, leading to apoptosis. Blocking EGFR degradation at various steps of this pathway reduces gemcitabine-mediated cytotoxicity. Whether an EGFR-activating insult leads to cell survival or cell death may ultimately be determined by the severity and duration of the stress. The colored arrows indicate the effects mediated by gemcitabine (red) versus radiation (blue). Dotted lines indicate less pronounced effects.
Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: A review

Publication

Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: A review. () Meredith A. Morgan, et al. Clin Cancer Res. ;14(21):6744-6750. Figure: F3.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates ATM ATM ncbigene_symbol ATM 472
Homo sapiens Primates ATR ATR ncbigene_symbol ATR 545
Homo sapiens Primates ATR ATR ncbigene_synonym ANTXR1 84168
Homo sapiens Primates ATR ATR ncbigene_synonym MMAB 326625
Homo sapiens Primates ATR ATR ncbigene_synonym SERPINA2 390502
Homo sapiens Primates Chk1/2 CHK2 ncbigene_synonym CHEK2 11200
Homo sapiens Primates Chk1/2 CHK1 ncbigene_synonym CHEK1 1111
Homo sapiens Primates EGFR EGFR ncbigene_symbol EGFR 1956
Homo sapiens Primates Ras RAS famplex_relations KRAS 3845
Homo sapiens Primates Ras RAS famplex_relations HRAS 3265
Homo sapiens Primates Ras RAS famplex_relations NRAS 4893
Homo sapiens Primates DNA-PK DNAPK ncbigene_synonym PRKDC 5591
Homo sapiens Primates Cdc25A CDC25A ncbigene_symbol CDC25A 993
Homo sapiens Primates Rad51 RAD51 ncbigene_symbol RAD51 5888
Homo sapiens Primates Cdk CDK famplex_relations CDKL1 8814
Homo sapiens Primates Cdk CDK famplex_relations CDKL2 8999
Homo sapiens Primates Cdk CDK famplex_relations CDKL3 51265
Homo sapiens Primates Cdk CDK famplex_relations CDKL4 344387
Homo sapiens Primates Cdk CDK famplex_relations CDKL5 6792
Homo sapiens Primates Cdk CDK famplex_relations CDK3 1018
Homo sapiens Primates Cdk CDK famplex_relations CDK4 1019
Homo sapiens Primates Cdk CDK famplex_relations CDK5 1020
Homo sapiens Primates Cdk CDK famplex_relations CDK6 1021
Homo sapiens Primates Cdk CDK famplex_relations CDK7 1022
Homo sapiens Primates Cdk CDK famplex_relations CDK8 1024
Homo sapiens Primates Cdk CDK famplex_relations CDK9 1025
Homo sapiens Primates Cdk CDK famplex_relations CDK10 8558
Homo sapiens Primates Cdk CDK famplex_relations CDK11A 728642
Homo sapiens Primates Cdk CDK famplex_relations CDK11B 984
Homo sapiens Primates Cdk CDK famplex_relations CDK12 51755
Homo sapiens Primates Cdk CDK famplex_relations CDK13 8621
Homo sapiens Primates Cdk CDK famplex_relations CDK14 5218
Homo sapiens Primates Cdk CDK famplex_relations CDK15 65061
Homo sapiens Primates Cdk CDK famplex_relations CDK16 5127
Homo sapiens Primates Cdk CDK famplex_relations CDK17 5128
Homo sapiens Primates Cdk CDK famplex_relations CDK18 5129
Homo sapiens Primates Cdk CDK famplex_relations CDK19 23097
Homo sapiens Primates Cdk CDK famplex_relations CDK20 23552
Homo sapiens Primates Cdk CDK famplex_relations CDK1 983
Homo sapiens Primates Cdk CDK famplex_relations CDK2 1017
Homo sapiens Primates AKT AKT ncbigene_synonym AKT1 207
Homo sapiens Primates AKT AKT famplex_relations AKT2 208
Homo sapiens Primates AKT AKT famplex_relations AKT3 10000

Chemical mentions

Word Match MeSH Name ChEBI
Gemcitabine gemcitabine mesh:C056507 gemcitabine chebi:175901

Disease mentions

Word Match MeSH Name DOID
Cancer NA